(Q49019886)

17 February 2018

title

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation? (English)

1 reference

17 February 2018

1 reference

1 reference

Münch G

1

1 reference

17 February 2018

Lüth HJ

2

1 reference

17 February 2018

Wong A

3

1 reference

17 February 2018

Arendt T

4

1 reference

17 February 2018

Hirsch E

5

1 reference

17 February 2018

Ravid R

6

1 reference

17 February 2018

Riederer P

7

1 reference

17 February 2018

publication date

1 December 2000

1 reference

17 February 2018

Journal of Chemical Neuroanatomy

published in

1 reference

17 February 2018

volume

20

1 reference

17 February 2018

issue

3-4

1 reference

17 February 2018

page(s)

253-257

1 reference

17 February 2018

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Sequestration of iron by Lewy bodies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Understanding cell death in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Parkinson's disease: a major hypokinetic basal ganglia disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Early contribution of oxidative glycation in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

Distribution of advanced glycation end products in the cerebellar neurons of dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900096-X

7 January 2021

10.1016/S0891-0618(00)00096-X

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018